The Phase 3 Biotech Leadership Podcast

Building Effective Teams and Career Success ft. Bob Ferrigno

In this episode of The Phase 3 Biotech Leadership Podcast, we are joined by Bob Ferrigno, Sr. Vice President of Global Sales and Marketing at SynergEyes, who shared insights from his extensive career in the biotech industry, focusing on leadership, team-building, and career development. Bob discusses his assertive career management at Becton Dickinson, where he held 15 different positions over 32 years, and his experiences working in various geographical markets. The conversation delves into his strategies for managing without authority, the importance of psychological safety, and how to drive success in both large and small companies. Learn from Bob's journey as he explains his approach to profiling, strategic planning, and navigating the complexities of business leadership. Follow Us: * Phase 3 Search [https://www.linkedin.com/company/phase-3-search/] * Bob Ferrigno [https://www.linkedin.com/in/bob-ferrigno-76b20a11b/] * Alex Cooke [https://www.linkedin.com/in/alexfcooke/]

The Importance of Mastering Change as a Biotech Leader ft. Dan Couto

In this episode of the Phase 3 Biotech Leadership Podcast, we sit down with Dan Couto, Chief Operating Officer of Vedanta Biosciences, [https://www.linkedin.com/in/daniel-couto-966bb24] to explore the critical role of mastering change in biotech leadership. Dan shares his diverse experiences across the biotech sector, highlighting key leadership skills such as problem-solving, effective communication, and relationship-building. Throughout the episode, Dan provides valuable insights into navigating financial challenges, fostering strong team dynamics, and adopting new technologies. Whether you're an aspiring business leader or an experienced professional, this episode offers actionable advice on how to drive success in the ever-evolving biotech landscape. Tune in for a wealth of knowledge on becoming a dynamic and adaptive leader in biotech. Follow Us: * Phase 3 Search [https://www.linkedin.com/company/phase-3-search/] * Dan Couto [https://www.linkedin.com/in/daniel-couto-966bb24/] * Alex Cooke [https://www.linkedin.com/in/alexfcooke/]

How to Transcend Your Function and Become a Holistic Biotech Business Leader - ft. Shawnte Mitchell

In this episode of The Phase 3 Biotech Leadership Podcast, we welcome Shawnte Mitchell, Chief Legal Officer, C-Suite Executive and Business Leader. Listen to the full episode to hear: * Shawnte share her unique career journey, highlighting major pivots from biological sciences to healthcare law and eventually into corporate leadership roles. * Alex and Shawnte discuss the importance of leaders transcending their functions to become more holistic business leaders, capable of cross-functional work at the C-suite and board levels. * The value of mentorship, diversity, and resilience in leadership, and insights into board dynamics and the importance of diverse perspectives. * More about Shawnte's involvement with the How Women Invest network, a group dedicated to supporting and empowering women in leadership and venture capital. Tune in for an enlightening discussion on the evolving demands of biotech leadership and the steps to become a more effective business leader. Follow us: Phase 3 Search: https://www.linkedin.com/company/phase-3-search [https://www.linkedin.com/company/phase-3-search] Alex Cooke: https://www.linkedin.com/in/alexfcooke/ [https://www.linkedin.com/in/alexfcooke/] Shawnte Mitchell https://www.linkedin.com/in/shawntemitchell/ [https://www.linkedin.com/in/shawntemitchell/] "How Women Invest": https://www.howwomeninvest.com/ [https://www.howwomeninvest.com/]

Best Practice for Late Stage Funding - Kameel Farag, Hari Pujar, Randy Berholtz

Our expert panel of C-level executives and board members reveal their tips tricks for successful late stage funding rounds. Great insight from: Hari Pujar - Operating Partner at Flagship Therapeutics and COO at Tessera Therapeutics Randy Berholtz - Chair and Chief Executive Officer Chair and Chief Executive Officer - Rancho Santa Fe Bio, Inc. Kameel Farag - CFO Aspen NeuroScience Hosted by Jared Green and Alex Cooke from Phase 3 Search www.ph3.bio

Best Practice for Early Stage VC Funding. Brian McVeigh, Doug Carlson, Mike Tusche

Our expert panel of hugley successful biotech C-leaders jump into best practices to ensure successful early fund raises in the biotech space. Having raised 100's of millions of dollars between them this is a great listen for all of those joining the fundraising roadshow. Doug Carlson - Cheif Operating and Financial Officer - Avenge Bio Mike Tusche - Co-CEO - Treadwell Therapeutics Brian McVeigh - CEO - Code Biotherapeutics Hosted by Jared Green and Alex Cooke from Phase 3 Search www.ph3.bio